Antonescu CR, Agaram NP, Sung YS, Zhang L, Swanson D, Dickson BC (2018) A distinct malignant epithelioid neoplasm with GLI1 gene rearrangements, frequent S100 protein expression, and metastatic potential: expanding the spectrum of pathologic entities with ACTB/MALAT1/PTCH1-GLI1 fusions. Am J Surg Pathol 42(4):553–560. https://doi.org/10.1097/PAS.0000000000001010

Article  PubMed  PubMed Central  Google Scholar 

Shabbir J, Earle J, Glomski K, Mnayer L, Schipper B, Ligato S (2024) Gastroblastoma with a novel ACTB::GLI1 gene fusion in a 19-year-old male. Virchows Archiv:n Int J Pathol. Advance online publication  https://doi.org/10.1007/s00428-024-03742-7

Papke DJ Jr, Dickson BC, Oliveira AM, Sholl LM, Fletcher CDM (2023) Distinctive nested glomoid neoplasm: clinicopathologic analysis of 20 cases of a mesenchymal neoplasm with frequent GLI1 alterations and indolent behavior. Am J Surg Pathol 47(1):12–24. https://doi.org/10.1097/PAS.0000000000001979

Article  PubMed  Google Scholar 

Lavernia J, Claramunt R, Romero I, López-Guerrero JA, Llombart-Bosch A, Machado I (2024) Soft tissue sarcomas with chromosomal alterations in the 12q13-15 region: differential diagnosis and therapeutic implications. Cancers 16(2):432. https://doi.org/10.3390/cancers16020432

Article  CAS  PubMed  PubMed Central  Google Scholar 

Prall OWJ, McEvoy CRE, Byrne DJ, Iravani A, Browning J, Choong DY, Yellapu B, O’Haire S, Smith K, Luen SJ, Mitchell PLR, Desai J, Fox SB, Fellowes A, Xu H (2020) A malignant neoplasm from the Jejunum with a MALAT1-GLI1 fusion and 26-year survival history. Int J Surg Pathol 28(5):553–562. https://doi.org/10.1177/1066896919900548

Article  CAS  PubMed  Google Scholar 

Kerr DA, Pinto A, Subhawong TK, Wilky BA, Schlumbrecht MP, Antonescu CR, Nielsen GP, Rosenberg AE (2019) Pericytoma with t(7;12) and ACTB-GLI1 fusion: reevaluation of an unusual entity and its relationship to the spectrum of GLI1 fusion-related neoplasms. Am J Surg Pathol 43(12):1682–1692. https://doi.org/10.1097/PAS.0000000000001360

Article  PubMed  PubMed Central  Google Scholar 

Pettus JR, Kerr DA, Stan RV, Tse JY, Sverrisson EF, Bridge JA, Linos K (2021) Primary myxoid and epithelioid mesenchymal tumor of the kidney with a novel GLI1-FOXO4 fusion. Genes Chromosom Cancer 60(2):116–122. https://doi.org/10.1002/gcc.22916

Article  CAS  PubMed  Google Scholar 

Miettinen M, Felisiak-Golabek A, Luiña Contreras A, Glod J, Kaplan RN, Killian JK, Lasota J (2019) New fusion sarcomas: histopathology and clinical significance of selected entities. Hum Pathol 86:57–65. https://doi.org/10.1016/j.humpath.2018.12.006

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dahlén A, Fletcher CD, Mertens F, Fletcher JA, Perez-Atayde AR, Hicks MJ, Debiec-Rychter M, Sciot R, Wejde J, Wedin R, Mandahl N, Panagopoulos I (2004) Activation of the GLI oncogene through fusion with the beta-actin gene (ACTB) in a group of distinctive pericytic neoplasms: pericytoma with t(7;12). Am J Pathol 164(5):1645–1653. https://doi.org/10.1016/s0002-9440(10)63723-6

Article  PubMed  PubMed Central  Google Scholar 

Bond SR, Lau A, Penuela S, Sampaio AV, Underhill TM, Laird DW, Naus CC (2011) Pannexin 3 is a novel target for Runx2, expressed by osteoblasts and mature growth plate chondrocytes. J Bone Miner Res: Off J Am Soc Bone Miner Res 26(12):2911–2922. https://doi.org/10.1002/jbmr.509

Article  CAS  Google Scholar 

Agaimy A (2020) What is new in epithelioid soft tissue tumors? Virchows Archiv: Int J Pathol 476(1):81–96. https://doi.org/10.1007/s00428-019-02677-8

Article  CAS  Google Scholar 

Miyashita H, Yoshida K, Soma T, Kameyama K, Sasaki A, Hisaoka M, Yazawa M, Morioka H, Takahashi M, Nakagawa T, Kawana H (2018) Dedifferentiated parosteal osteosarcoma of the maxilla: a case report and review of the literature. J Med Case Rep 12(1):235. https://doi.org/10.1186/s13256-018-1747-3

Article  PubMed  PubMed Central  Google Scholar 

Yamagata K, Ishibashi-Kanno N, Matsuoka R, Uchida F, Fukuzawa S, Bukawa H (2022) Dedifferentiated low-grade central osteosarcoma of the mandible. Case Rep Dentistry 2022:9321728. https://doi.org/10.1155/2022/9321728

Article  Google Scholar 

Liu J, Mao R, Lao IW, Yu L, Bai Q, Zhou X, Wang J (2022) GLI1-altered mesenchymal tumor: a clinicopathological and molecular analysis of ten additional cases of an emerging entity. Virchows Archiv: Int J Pathol 480(5):1087–1099. https://doi.org/10.1007/s00428-021-03224-0

Article  CAS  Google Scholar 

Palsgrove DN, Rooper LM, Stevens TM, Shin C, Damm DD, Gagan J, Bridge JA, Thompson LDR, Koduru PR, Bishop JA (2022) GLI1-altered soft tissue tumors of the head and neck: frequent oropharyngeal involvement, p16 immunoreactivity, and detectable alterations by DDIT3 break apart FISH. Head Neck Pathol 16(4):1146–1156. https://doi.org/10.1007/s12105-022-01476-z

Article  PubMed  PubMed Central  Google Scholar 

Machado I, Agaimy A, Giner F, Navarro S, Michal M, Bridge J, Claramunt R, López-Guerrero JA, Alcacer J, Linos K, Llombart-Bosch A (2024) The value of GLI1 and p16 immunohistochemistry in the premolecular screening for GLI1-altered mesenchymal neoplasms. Virchows Archiv: Int J Pathol 484(5):765–775. https://doi.org/10.1007/s00428-023-03687-3

Article  CAS  Google Scholar 

Saoud C, Agaimy A, Dermawan JK, Chen JF, Rosenblum MK, Dickson BC, Dashti N, Michal M, Kosemehmetoglu K, Din NU, Albritton K, Agaram NP, Antonescu CR (2024) A comprehensive clinicopathologic and molecular reappraisal of GLI1-altered mesenchymal tumors with pooled outcome analysis showing poor survival in GLI1-amplified versus GLI1-rearranged tumors. Am J Surg Pathol. Advance online publication https://doi.org/10.1097/PAS.0000000000002272

Agaram NP, Zhang L, Sung YS, Singer S, Stevens T, Prieto-Granada CN, Bishop JA, Wood BA, Swanson D, Dickson BC, Antonescu CR (2019) GLI1-amplifications expand the spectrum of soft tissue neoplasms defined by GLI1 gene fusions. Modern Pathol: Off J U S Can Acad Pathol Inc 32(11):1617–1626. https://doi.org/10.1038/s41379-019-0293-x

Spans L, Fletcher CD, Antonescu CR, Rouquette A, Coindre JM, Sciot R, Debiec-Rychter M (2016) Recurrent MALAT1-GLI1 oncogenic fusion and GLI1 up-regulation define a subset of plexiform fibromyxoma. J Pathol 239(3):335–343. https://doi.org/10.1002/path.4730

Article  CAS  PubMed  PubMed Central  Google Scholar 

Graham RP, Nair AA, Davila JI, Jin L, Jen J, Sukov WR, Wu TT, Appelman HD, Torres-Mora J, Perry K D, Zhang L, Kloft-Nelson SM, Knudson RA, Greipp PT, and Folpe AL (2017) Gastroblastoma harbors a recurrent somatic MALAT1-GLI1 fusion gene. Modern Pathol: Off J U S Can Acad Pathol Inc 30(10):1443–1452. https://doi.org/10.1038/modpathol.2017.68

Romano RC, Gardner JM, Shalin SC, Ram R, Govindarajan R, Montgomery CO, Gilley JH, Nicholas RW (2016) High relative expression of Pannexin 3 (PANX3) in an axillary sweat gland carcinoma with osteosarcomatous transformation. Am J Dermatopathol 38(11):846–851. https://doi.org/10.1097/DAD.0000000000000583

Article  PubMed  Google Scholar